Lv1
20 积分 2024-05-08 加入
Neoadjuvant camrelizumab plus chemotherapy for locally advanced cervical cancer (NACI Study): A prospective, single-arm, phase II trial
18小时前
已完结
ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity
11个月前
已完结
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
1年前
已完结
皖公网安备34019202002308
